Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Operating Margin (2022 - 2024)

Werewolf Therapeutics (HOWL) has disclosed Operating Margin for 3 consecutive years, with 1658.79% as the latest value for Q2 2024.

  • Quarterly Operating Margin fell 158372.0% to 1658.79% in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 6511.2% through Mar 2025, down 623106.0% year-over-year, with the annual reading at 3904.19% for FY2024, 370110.0% down from the prior year.
  • Operating Margin for Q2 2024 was 1658.79% at Werewolf Therapeutics, up from 2312.94% in the prior quarter.
  • The five-year high for Operating Margin was 75.08% in Q2 2023, with the low at 2312.94% in Q1 2024.
  • Average Operating Margin over 3 years is 681.69%, with a median of 273.81% recorded in 2023.
  • The sharpest move saw Operating Margin soared 28587bps in 2023, then crashed -203913bps in 2024.
  • Over 3 years, Operating Margin stood at 180.96% in 2022, then tumbled by -377bps to 863.56% in 2023, then plummeted by -92bps to 1658.79% in 2024.
  • According to Business Quant data, Operating Margin over the past three periods came in at 1658.79%, 2312.94%, and 863.56% for Q2 2024, Q1 2024, and Q4 2023 respectively.